08:00 , Dec 11, 2008 |  BC Innovations  |  Distillery Therapeutics

This week in therapeutics

The Distillery: Therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Congestive heart failure (CHF) Four and a half LIM domains 1 (FHL1) A study in mice suggests that inhibiting FHL1 may...